Page last updated: 2024-09-04

ym 09151-2 and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride

ym 09151-2 has been researched along with 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride in 1 studies

Compound Research Comparison

Studies
(ym 09151-2)
Trials
(ym 09151-2)
Recent Studies (post-2010)
(ym 09151-2)
Studies
(1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride)
Trials
(1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride)
Recent Studies (post-2010) (1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride)
249613113241

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishiwata, K; Kawamura, K; Kobayashi, T; Matsuno, K1

Other Studies

1 other study(ies) available for ym 09151-2 and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride

ArticleYear
Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands.
    Nuclear medicine and biology, 2003, Volume: 30, Issue:4

    Topics: Animals; Benzamides; Brain; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Haloperidol; Injections, Intraperitoneal; Ligands; Male; Mice; Nootropic Agents; Piperazines; Raclopride; Receptors, Dopamine D2; Receptors, sigma

2003